[1]
S. M. Al-killidar and B. M. Muhammad-Baqir, “Empagliflozin attenuates inflammation and myocardial injury in a murine model of sepsis”, Babcock Univ. Med. J., vol. 8, no. 2, pp. 217–225, Dec. 2025.